- Home
- NAUT vs SOPH Comparison
NAUT vs SOPH Comparison
Compare NAUT & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAUT
- SOPH
- Stock Information
- Founded
- NAUT 2016
- SOPH 2011
- Country
- NAUT United States
- SOPH Switzerland
- Employees
- NAUT N/A
- SOPH N/A
- Industry
- NAUT Biotechnology: Laboratory Analytical Instruments
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NAUT Industrials
- SOPH Health Care
- Exchange
- NAUT Nasdaq
- SOPH Nasdaq
- Market Cap
- NAUT 188.3M
- SOPH 206.6M
- IPO Year
- NAUT N/A
- SOPH 2021
- Fundamental
- Price
- NAUT $0.76
- SOPH $2.83
- Analyst Decision
- NAUT Hold
- SOPH Strong Buy
- Analyst Count
- NAUT 3
- SOPH 2
- Target Price
- NAUT $3.58
- SOPH $6.50
- AVG Volume (30 Days)
- NAUT 174.6K
- SOPH 36.0K
- Earning Date
- NAUT 04-29-2025
- SOPH 05-06-2025
- Dividend Yield
- NAUT N/A
- SOPH N/A
- EPS Growth
- NAUT N/A
- SOPH N/A
- EPS
- NAUT N/A
- SOPH N/A
- Revenue
- NAUT N/A
- SOPH $65,173,000.00
- Revenue This Year
- NAUT N/A
- SOPH $14.83
- Revenue Next Year
- NAUT N/A
- SOPH $22.79
- P/E Ratio
- NAUT N/A
- SOPH N/A
- Revenue Growth
- NAUT N/A
- SOPH 4.49
- 52 Week Low
- NAUT $0.66
- SOPH $2.60
- 52 Week High
- NAUT $3.09
- SOPH $6.28
- Technical
- Relative Strength Index (RSI)
- NAUT 38.87
- SOPH 42.78
- Support Level
- NAUT $0.72
- SOPH $2.60
- Resistance Level
- NAUT $0.83
- SOPH $3.00
- Average True Range (ATR)
- NAUT 0.11
- SOPH 0.32
- MACD
- NAUT 0.02
- SOPH -0.00
- Stochastic Oscillator
- NAUT 39.20
- SOPH 25.84
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. It has built a prototype of a single-molecule instrument, Proteomic Analysis System.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.